Topics
Sector
Geography
Subject

Videos Library

Event Videos

PharmAccess Leaders Forum (Spring)

Milan, Italy - May 3-5, 2017
Presentation

The Patient as the Payer: What drives patients’ willingness-to-pay?

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Patient-Centricity & Care
Availability: FREE
Speaker

Adrien Gras
Vice President Europe, Market Access
GFK, UK

Presentation

Bio-similar, but different: Establishing (or defending) value through Multi-Criteria Decision Analytic (MCDA) modelling

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR, Biosimilars
Availability: FREE
  • How the complex characteristics of biologics (and biosimilars) contribute to perceived value to different stakeholders.
  • The salient issues facing Upstarts (marketers of biosimilars) and Defenders (marketers of “original” biologics) in communicating comparative worth to stakeholders.
  • How MCDA modelling methods can assist both groups in better defining and communicating value.
Speaker

Mason W. Russell
Vice President, Strategic Consulting (Life Sciences)
Truven, USA

Presentation

HTA in the changing development and regulatory landscape

Related topics: Pharmaceutical/Biotech, Europe, Market Access & HEOR
Availability: FREE
  • What is driving changes such as conditional market authorisation and adaptive pathways?
  • What are the challenges for HTA agencies and their evaluation approaches?
  • What are the critical success factors for pharma companies?
Speaker

Anke van Engen
Principal, Consulting Services
QuintilesIMS